Announcements
- Positive FDA Feedback to Progress Bexmarilimab
- Notice of Faron Pharmaceuticals Ltd’s AGM
- Faron´s Annual Report 2022 Published
- Financial Statement January 1 to December 31 2022
- Update to Faron’s Financial Calendar for 2023
- Notice of 2022 Full-Year Results and Annual Report
- Holding(s) in Company
- Results of Placing
- Proposed Issue and Placing
- Price Monitoring Extension
More ▼
Key statistics
On Thursday, Faron Pharmaceuticals Oy (FARON:HEX) closed at 3.70, -25.55% below its 52-week high of 4.97, set on Dec 07, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.70 |
---|---|
High | 3.70 |
Low | 3.61 |
Bid | -- |
Offer | -- |
Previous close | 3.64 |
Average volume | 14.53k |
---|---|
Shares outstanding | 63.50m |
Free float | 34.22m |
P/E (TTM) | -- |
Market cap | 200.33m GBP |
EPS (TTM) | -0.4577 GBP |
Data delayed at least 15 minutes, as of Mar 23 2023 17:00 BST.
More ▼